Area riservata



La dieta mediterranea

FDA approves new multiple sclerosis treatment Aubagio
Scritto da FDA Press Releases   
Scienza-dell-alimentazionehe U.S. Food and Drug Administration today approved Aubagio (teriflunomide), a once-a-day tablet for the treatment of adults with relapsing forms of multiple sclerosis (MS).
Fonte: FDA Press Releases
 

Aggiungi commento



Aggiorna